Literature DB >> 26342081

Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway.

Sophie Trefely1, Poh-Sim Khoo2, James R Krycer3, Rima Chaudhuri3, Daniel J Fazakerley3, Benjamin L Parker3, Ghazal Sultani1, James Lee4, Jean-Philippe Stephan4, Eric Torres4, Kenneth Jung4, Coenraad Kuijl4, David E James5, Jagath R Junutula6, Jacqueline Stöckli7.   

Abstract

The insulin/insulin-like growth factor (IGF)-1 signaling pathway (ISP) plays a fundamental role in long term health in a range of organisms. Protein kinases including Akt and ERK are intimately involved in the ISP. To identify other kinases that may participate in this pathway or intersect with it in a regulatory manner, we performed a whole kinome (779 kinases) siRNA screen for positive or negative regulators of the ISP, using GLUT4 translocation to the cell surface as an output for pathway activity. We identified PFKFB3, a positive regulator of glycolysis that is highly expressed in cancer cells and adipocytes, as a positive ISP regulator. Pharmacological inhibition of PFKFB3 suppressed insulin-stimulated glucose uptake, GLUT4 translocation, and Akt signaling in 3T3-L1 adipocytes. In contrast, overexpression of PFKFB3 in HEK293 cells potentiated insulin-dependent phosphorylation of Akt and Akt substrates. Furthermore, pharmacological modulation of glycolysis in 3T3-L1 adipocytes affected Akt phosphorylation. These data add to an emerging body of evidence that metabolism plays a central role in regulating numerous biological processes including the ISP. Our findings have important implications for diseases such as type 2 diabetes and cancer that are characterized by marked disruption of both metabolism and growth factor signaling.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt PKB; PFKFB3; Warburg effect; glucose metabolism; glucose transporter type 4 (GLUT4); glycolysis; insulin

Mesh:

Substances:

Year:  2015        PMID: 26342081      PMCID: PMC4646237          DOI: 10.1074/jbc.M115.658815

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  103 in total

1.  The cytosolic C-terminus of the glucose transporter GLUT4 contains an acidic cluster endosomal targeting motif distal to the dileucine signal.

Authors:  A M Shewan; B J Marsh; D R Melvin; S Martin; G W Gould; D E James
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  The RabGAP TBC1D1 plays a central role in exercise-regulated glucose metabolism in skeletal muscle.

Authors:  Jacqueline Stöckli; Christopher C Meoli; Nolan J Hoffman; Daniel J Fazakerley; Himani Pant; Mark E Cleasby; Xiuquan Ma; Maximilian Kleinert; Amanda E Brandon; Jamie A Lopez; Gregory J Cooney; David E James
Journal:  Diabetes       Date:  2015-01-09       Impact factor: 9.461

4.  Anticancer drugs: a clearer pathway view.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

5.  Akt mediates insulin induction of glucose uptake and up-regulation of GLUT4 gene expression in brown adipocytes.

Authors:  R Hernandez; T Teruel; M Lorenzo
Journal:  FEBS Lett       Date:  2001-04-13       Impact factor: 4.124

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

Authors:  Joanne R Doherty; Chunying Yang; Kristen E N Scott; Michael D Cameron; Mohammad Fallahi; Weimin Li; Mark A Hall; Antonio L Amelio; Jitendra K Mishra; Fangzheng Li; Mariola Tortosa; Heide Marika Genau; Robert J Rounbehler; Yunqi Lu; Chi V Dang; K Ganesh Kumar; Andrew A Butler; Thomas D Bannister; Andrea T Hooper; Keziban Unsal-Kacmaz; William R Roush; John L Cleveland
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

8.  Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation.

Authors:  Andrew J Hoy; Amanda E Brandon; Nigel Turner; Matthew J Watt; Clinton R Bruce; Gregory J Cooney; Edward W Kraegen
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-04-14       Impact factor: 4.310

9.  Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells.

Authors:  Lucía Cordero-Espinoza; Thilo Hagen
Journal:  J Biol Chem       Date:  2013-10-29       Impact factor: 5.157

10.  Nucleoside diphosphate kinase (NDPK, NM23, AWD): recent regulatory advances in endocytosis, metastasis, psoriasis, insulin release, fetal erythroid lineage and heart failure; translational medicine exemplified.

Authors:  Anil Mehta; Sandra Orchard
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

View more
  18 in total

1.  PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.

Authors:  Helga Simon-Molas; Claudia Arnedo-Pac; Pere Fontova; Anna Vidal-Alabró; Esther Castaño; Ana Rodríguez-García; Àurea Navarro-Sabaté; Núria Lloberas; Anna Manzano; Ramon Bartrons
Journal:  Mol Cell Biochem       Date:  2018-02-12       Impact factor: 3.396

2.  Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells.

Authors:  Joshua K Salabei; Pawel K Lorkiewicz; Parul Mehra; Andrew A Gibb; Petra Haberzettl; Kyung U Hong; Xiaoli Wei; Xiang Zhang; Qianhong Li; Marcin Wysoczynski; Roberto Bolli; Aruni Bhatnagar; Bradford G Hill
Journal:  J Biol Chem       Date:  2016-05-05       Impact factor: 5.157

Review 3.  Muscle and adipose tissue insulin resistance: malady without mechanism?

Authors:  Daniel J Fazakerley; James R Krycer; Alison L Kearney; Samantha L Hocking; David E James
Journal:  J Lipid Res       Date:  2018-07-27       Impact factor: 5.922

4.  Is Estrogen a Missing Culprit in Thyroid Eye Disease? Sex Steroid Hormone Homeostasis Is Key to Other Fibrogenic Autoimmune Diseases - Why Not This One?

Authors:  Amy M FitzPatrick
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 5.  Integrating adipocyte insulin signaling and metabolism in the multi-omics era.

Authors:  C Martinez Calejman; W G Doxsey; D J Fazakerley; D A Guertin
Journal:  Trends Biochem Sci       Date:  2022-03-15       Impact factor: 14.264

Review 6.  The aetiology and molecular landscape of insulin resistance.

Authors:  David E James; Jacqueline Stöckli; Morris J Birnbaum
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-20       Impact factor: 94.444

7.  RABIF/MSS4 is a Rab-stabilizing holdase chaperone required for GLUT4 exocytosis.

Authors:  Daniel R Gulbranson; Eric M Davis; Brittany A Demmitt; Yan Ouyang; Yihong Ye; Haijia Yu; Jingshi Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

8.  PFKFB3-dependent glucose metabolism regulates 3T3-L1 adipocyte development.

Authors:  Beth A Griesel; Satoshi Matsuzaki; Albert Batushansky; Timothy M Griffin; Kenneth M Humphries; Ann Louise Olson
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

9.  MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism.

Authors:  Charlotte Petersen; Mette D Nielsen; Elise S Andersen; Astrid L Basse; Marie S Isidor; Lasse K Markussen; Birgitte M Viuff; Ian H Lambert; Jacob B Hansen; Stine F Pedersen
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

10.  Revisiting the IGF-1R as a breast cancer target.

Authors:  Roudy Chiminch Ekyalongo; Douglas Yee
Journal:  NPJ Precis Oncol       Date:  2017-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.